Route transition interventions: Potential public health gains from reducing or preventing injecting

International Journal of Drug Policy

Volumn 21, Issue 2, 2010, Pages 125-128

  Bridge, Jamie ^a  

^a TUBERCULOSIS AND MALARIA   (Switzerland)

Author keywords

Chasing; Illicit Drugs; Injecting; NIROA; Route transitions

Indexed keywords

ILLICIT DRUG;

ARTICLE; BEHAVIOR CHANGE; DRUG CONTROL; EMPOWERMENT; HARM REDUCTION; HEALTH PROMOTION; HEROIN DEPENDENCE; HIGH RISK BEHAVIOR; INTRAVENOUS DRUG ABUSE; MOTIVATION; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SOCIAL MARKETING; STIGMA;

EID: 77949264160     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2010.01.011     Document Type: Note

References (43)

1. Aceijas C., Stimson G.V., Hickman M., Rhodes T., and The United Nations Reference Group on HIV/AIDS Prevention and Care among IDU in Developing and Transitional Countries. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 18 (2004) 2295-2303
2. AIDSMark. Regional lessons learned: eastern Europe (2007), Population Services International, Washington DC
3. Barrio G., De La Fuente L., Royuela L., Díaz A., Rodríguez-Artalejo F., and The Spanish Group for the Study on the Route of Administration of Drugs. Cocaine use among heroin users in Spain: The diffusion of crack and cocaine smoking. Journal of Epidemiology and Community Health 52 (1998) 172-180
4. Bravo M.J., Barrio G., De La Fuente L., Royuela L., Domingo L., and Silva T. Reasons for selecting an initial route of heroin administration and for subsequent transitions during a severe HIV epidemic. Addiction 98 (2003) 749-760
5. Brener, L., Spooner, C., Treloar, C. (2009). Preventing transitions to injecting among young people: What is the role of needle and syringe programmes? International Journal of Drug Policy, [Epub ahead of print].
6. Cook C., and Kanaef N. Global state of harm reduction 2008: Mapping the response to drug-related HIV and hepatitis C epidemics (2008), International Harm Reduction Association, London
7. Darke S., and Ross J. Fatal heroin overdoses resulting from non-injecting routes of administration, NSW, Australia, 1992-1996. Addiction 94 (2000) 569-573
8. De La Fuente L., Barrio G., Royuela L., Bravo M.J., and The Spanish Group for the Study on the Route of Heroin Administration. The transition from injecting to smoking heroin in three Spanish cities. Addiction 92 (1997) 1749-1763
9. Des Jarlais D.C., Casriel C., Friedman S.R., and Rosenblum A. AIDS and the transition to illicit drug injection: Results of a randomized trial prevention program. Addiction 87 (1992) 493-498
10. Des Jarlais D.C., Arasteh K., Perlis T., Hagan H., Heckathorn D.D., McKnight C., Bramson H., and Friedman S.R. The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City. Addiction 102 (2007) 778-785
11. Dewing S., Plüddemann A., Myers B.J., and Parry C.D.H. Review of injection drug use in six African countries: Egypt, Kenya, Mauritius, Nigeria, South Africa and Tanzania. Drugs: Education, Prevention and Policy 13 (2006) 121-137
12. Dolan K., Clement N., Rouen D., Rees V., Shearer J., and Wodak A. Can drug injectors be encouraged to adopt non-injecting routes of administration (NIROA) for drugs?. Drug and Alcohol Review 23 (2004) 281-286
13. Gartner C.E., Hall W., and Chapman S. Should the health community promote smokeless tobacco (snus) as a harm reduction measure?. PloS Medicine 7 (2007) 1138-1141
14. Gossop M., Stewart D., Marsden J., Kidd T., and Strang J. Changes in route of drug administration among continuing heroin users: Outcomes 1 year after intake to treatment. Addictive Behaviors 29 (2004) 1085-1094
15. Grund J.C. Drug use as a social ritual: functionality, symbolism and determinants of self-regulation (1993), Instituut voor Verslavingsonderzoek, Rotterdam
16. Halligan E. Transitioning to injecting: What's it all about?. NUAA Users News 55 (2008) (Summer)
17. Hunt N., Stillwell G., Taylor C., and Griffiths P. Evaluation of a brief intervention to prevent initiation into injecting. Drugs: Education, Prevention and Policy 5 (1998) 185-194
18. Hunt N., Preston A., and Stillwell G. A guide to assessing 'route transitions' and developing interventions that promote safer drug use (2005), Exchange Supplies, Dorchester
19. Kools, J. (in press). The Dutch experience in promoting transition away from injecting drug use, 1991-2009. Dorchester: Exchange Supplies.
20. Langendam M.W., Van Brussel G.H.A., Coutinho R.A., and Van Ameijden E.J.C. Methadone maintenance and cessation of injecting drug use: Results from the Amsterdam cohort study. Addiction 95 (2000) 591-600
21. Leonard L., DeRubeis E., Pelude L., Medd E., Birkett N., and Seto J. "I inject less as I have easier access to pipes": Injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed. International Journal of Drug Policy 19 (2008) 255-264
22. Matsumoto T., Kamijo A., Miyakawa T., Endo K., Yabana T., Kishimoto H., Okudaira K., Iseki E., Sakai T., and Kosaka K. Methamphetamine in Japan: The consequences of methamphetamine abuse as a function of route of administration. Addiction 97 (2002) 809-817
23. McNeill A., and Bridge J. Seeing past the smoke. Drink and Drug News April 23 (2007) 10-11
24. Neaigus A., Gyarmathy V.A., Miller M., Frajzyngier V.M., Friedman S.R., and Des Jarlais D.C. Transitions to injecting drug use among noninjecting heroin users: Social network influence and individual susceptibility. Journal of Acquired Immune Deficiency Syndrome 41 (2006) 493-503
25. Palmateer N., Kimber J., Hickman M., Hutchinson S., Rhodes T., and Goldberg D. Evidence for the effectiveness of harm reduction interventions in preventing hepatitis C transmission among injecting drug users: A review of reviews. Report for the Prevention Working Groups of the Advisory Council on the Misuse of Drugs and the Hepatitis C Action Plan for Scotland (2009)
26. Pizzey R., and Hunt N. Distributing foil from needle and syringe programmes (NSPs) to promote transitions from heroin injecting to chasing: An evaluation. Harm Reduction Journal 5 (2008) 24
27. Robertson J.R., Ronald P.J.M., Raab G.M., Ross A.J., and Parpia T. Deaths, HIV infection, abstinence, and other outcomes in a cohort of injecting drug users followed up for 10 years. British Medical Journal 309 (1994) 369-372
28. Scheinmann R., Hagan H., Lelutiu-Weinberger C., Stern R., Des Jarlais D.C., Flom P.L., and Strauss S. Non-injection drug use and hepatitis C virus: A systematic review. Drug and Alcohol Dependence 89 (2007) 1-12
29. Seanor D., Alcabes P., and Drucker E. Tobacco harm reduction How rationale public policy could transform a pandemic. International Journal of Drug Policy 18 (2007) 70-74
30. Shannon K., Ishida T., Morgan R., Bear A., Oleson M., Kerr T., and Tyndall M.W. Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users. Harm Reduction Journal 3 (2006) 1
31. Sibthorpe B., and Lear B. Circumstances surrounding needle use transitions among injection drug users: Implications for HIV intervention. International Journal of the Addictions 29 (1994) 1245-1257
32. Southwell, M. (1997). "Up Your Bum": A Simple, Safer Route of Drug Taking or a Squirt Too Far? Retrieved 29th September 2009 www.drugtext.org/library/articles/southwell02.htm.
33. Southwell M. Transitions to and from injecting. In: Pates R., McBride A., and Arnold K. (Eds). Injecting illicit drugs (2005), Blackwell Publishing Ltd., Oxford 118-134
34. Stimson G.V. The global diffusion of injecting drug use: Implications for human immunodeficiency infection. Bulletin on Narcotics 45 (1993) 3-12
35. Stimson G.V., Adelekan M., and Rhodes T. The diffusion of drug injecting in developing countries. International Journal of Drug Policy 7 (1996) 245-255
36. Stimson G.V., and Choopanya K. Global perspectives on drug injecting. In: Stimson G.V., Des Jarlais D.C., and Ball A. (Eds). Drug injecting and HIV infection: global dimensions and local responses (1998), UCL Press, London
37. Strang J., Griffiths P., Powis B., and Gossop M. First use of heroin: Changes in route of administration over time. British Medical Journal 304 (1992) 1222-1223
38. Strang J., Griffiths P., Powis B., Abbey J., and Gossop M. How constant is an individual's route of heroin administration? Data from treatment and non-treatment samples. Drug and Alcohol Dependence 46 (1997) 115-118
39. Strang J., Bearn J., Farrell M., Finch E., Gossop M., Griffiths P., Marsden J., and Wolff K. Route of drug use and its implications for drug effect, risk of dependence and health consequences. Drug and Alcohol Review 17 2 (1998) 197-211
40. Van Ameijden E.J.C., and Coutinho R.A. Maximum impact of HIV prevention measures targeted at injecting drug users. AIDS 12 (1998) 625-633
41. Van Ameijden E.J.C., and Coutinho R.A. Large decline in injecting drug use in Amsterdam, 1986-1998: Explanatory mechanisms and determinants of injecting transitions. Journal of Epidemiology and Community Health 55 (2001) 356-363
42. Van Beek I. The POTTI Project: What it's all about!. NUAA Users News 56 (2009) (Autumn)
43. Witteveen E.J. Knowledge gained through experience in young problem drug users: reflections on interventions and change (2008), Universiteit van Amsterdam, Amsterdam